ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,211, issued on Oct. 21, was assigned to CytoKi Pharma ApS (Hellerup, Denmark).
"Therapeutic derivatives of interleukin-22" was invented by Kristian Sass-Orum (Bagsvaerd, Denmark), Rasmus Jorgensen (Hellerup, Denmark), Sebastian Beck Jorgensen (Bagsvaerd, Denmark), Henning Thogersen (Bagsvaerd, Denmark), Thomas Hoeg-Jensen (Bagsvaerd, Denmark) and Michael Paolo Bastner Sandrini (Bagsvaerd, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel derivatives of Interleukin-22 (IL-22), particularly those comprising a fatty acid covalently attached to an IL-22 protein, and their use in therapy."
The patent was filed on June...